Stephen Ross, Anthony Bossis, Jeffrey Guss, Gabrielle Agin-Liebes, Tara Malone, Barry Cohen, Sarah E Mennenga, Alexander Belser, Krystallia Kalliontzi, James Babb, Zhe Su, Patricia Corby, Brian L Schmidt. J Psychopharmacol 2016
Times Cited: 524
Times Cited: 524
Times Cited
Times Co-cited
Similarity
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
Roland R Griffiths, Matthew W Johnson, Michael A Carducci, Annie Umbricht, William A Richards, Brian D Richards, Mary P Cosimano, Margaret A Klinedinst. J Psychopharmacol 2016
Roland R Griffiths, Matthew W Johnson, Michael A Carducci, Annie Umbricht, William A Richards, Brian D Richards, Mary P Cosimano, Margaret A Klinedinst. J Psychopharmacol 2016
86
Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial.
Alan K Davis, Frederick S Barrett, Darrick G May, Mary P Cosimano, Nathan D Sepeda, Matthew W Johnson, Patrick H Finan, Roland R Griffiths. JAMA Psychiatry 2021
Alan K Davis, Frederick S Barrett, Darrick G May, Mary P Cosimano, Nathan D Sepeda, Matthew W Johnson, Patrick H Finan, Roland R Griffiths. JAMA Psychiatry 2021
53
Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.
Robin L Carhart-Harris, Mark Bolstridge, James Rucker, Camilla M J Day, David Erritzoe, Mendel Kaelen, Michael Bloomfield, James A Rickard, Ben Forbes, Amanda Feilding,[...]. Lancet Psychiatry 2016
Robin L Carhart-Harris, Mark Bolstridge, James Rucker, Camilla M J Day, David Erritzoe, Mendel Kaelen, Michael Bloomfield, James A Rickard, Ben Forbes, Amanda Feilding,[...]. Lancet Psychiatry 2016
52
Trial of Psilocybin versus Escitalopram for Depression.
Robin Carhart-Harris, Bruna Giribaldi, Rosalind Watts, Michelle Baker-Jones, Ashleigh Murphy-Beiner, Roberta Murphy, Jonny Martell, Allan Blemings, David Erritzoe, David J Nutt. N Engl J Med 2021
Robin Carhart-Harris, Bruna Giribaldi, Rosalind Watts, Michelle Baker-Jones, Ashleigh Murphy-Beiner, Roberta Murphy, Jonny Martell, Allan Blemings, David Erritzoe, David J Nutt. N Engl J Med 2021
52
Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.
Charles S Grob, Alicia L Danforth, Gurpreet S Chopra, Marycie Hagerty, Charles R McKay, Adam L Halberstadt, George R Greer. Arch Gen Psychiatry 2011
Charles S Grob, Alicia L Danforth, Gurpreet S Chopra, Marycie Hagerty, Charles R McKay, Adam L Halberstadt, George R Greer. Arch Gen Psychiatry 2011
45
Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.
R L Carhart-Harris, M Bolstridge, C M J Day, J Rucker, R Watts, D E Erritzoe, M Kaelen, B Giribaldi, M Bloomfield, S Pilling,[...]. Psychopharmacology (Berl) 2018
R L Carhart-Harris, M Bolstridge, C M J Day, J Rucker, R Watts, D E Erritzoe, M Kaelen, B Giribaldi, M Bloomfield, S Pilling,[...]. Psychopharmacology (Berl) 2018
44
Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.
Michael P Bogenschutz, Alyssa A Forcehimes, Jessica A Pommy, Claire E Wilcox, P C R Barbosa, Rick J Strassman. J Psychopharmacol 2015
Michael P Bogenschutz, Alyssa A Forcehimes, Jessica A Pommy, Claire E Wilcox, P C R Barbosa, Rick J Strassman. J Psychopharmacol 2015
43
Quality of Acute Psychedelic Experience Predicts Therapeutic Efficacy of Psilocybin for Treatment-Resistant Depression.
Leor Roseman, David J Nutt, Robin L Carhart-Harris. Front Pharmacol 2018
Leor Roseman, David J Nutt, Robin L Carhart-Harris. Front Pharmacol 2018
39
Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.
Matthew W Johnson, Albert Garcia-Romeu, Mary P Cosimano, Roland R Griffiths. J Psychopharmacol 2014
Matthew W Johnson, Albert Garcia-Romeu, Mary P Cosimano, Roland R Griffiths. J Psychopharmacol 2014
37
Human hallucinogen research: guidelines for safety.
Mw Johnson, Wa Richards, Rr Griffiths. J Psychopharmacol 2008
Mw Johnson, Wa Richards, Rr Griffiths. J Psychopharmacol 2008
35
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial.
Fernanda Palhano-Fontes, Dayanna Barreto, Heloisa Onias, Katia C Andrade, Morgana M Novaes, Jessica A Pessoa, Sergio A Mota-Rolim, Flávia L Osório, Rafael Sanches, Rafael G Dos Santos,[...]. Psychol Med 2019
Fernanda Palhano-Fontes, Dayanna Barreto, Heloisa Onias, Katia C Andrade, Morgana M Novaes, Jessica A Pessoa, Sergio A Mota-Rolim, Flávia L Osório, Rafael Sanches, Rafael G Dos Santos,[...]. Psychol Med 2019
32
Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects.
Roland R Griffiths, Matthew W Johnson, William A Richards, Brian D Richards, Una McCann, Robert Jesse. Psychopharmacology (Berl) 2011
Roland R Griffiths, Matthew W Johnson, William A Richards, Brian D Richards, Una McCann, Robert Jesse. Psychopharmacology (Berl) 2011
29
Psychedelics Promote Structural and Functional Neural Plasticity.
Calvin Ly, Alexandra C Greb, Lindsay P Cameron, Jonathan M Wong, Eden V Barragan, Paige C Wilson, Kyle F Burbach, Sina Soltanzadeh Zarandi, Alexander Sood, Michael R Paddy,[...]. Cell Rep 2018
Calvin Ly, Alexandra C Greb, Lindsay P Cameron, Jonathan M Wong, Eden V Barragan, Paige C Wilson, Kyle F Burbach, Sina Soltanzadeh Zarandi, Alexander Sood, Michael R Paddy,[...]. Cell Rep 2018
29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance.
R R Griffiths, W A Richards, U McCann, R Jesse. Psychopharmacology (Berl) 2006
R R Griffiths, W A Richards, U McCann, R Jesse. Psychopharmacology (Berl) 2006
28
Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases.
Peter Gasser, Dominique Holstein, Yvonne Michel, Rick Doblin, Berra Yazar-Klosinski, Torsten Passie, Rudolf Brenneisen. J Nerv Ment Dis 2014
Peter Gasser, Dominique Holstein, Yvonne Michel, Rick Doblin, Berra Yazar-Klosinski, Torsten Passie, Rudolf Brenneisen. J Nerv Ment Dis 2014
26
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.
Gabrielle I Agin-Liebes, Tara Malone, Matthew M Yalch, Sarah E Mennenga, K Linnae Ponté, Jeffrey Guss, Anthony P Bossis, Jim Grigsby, Stacy Fischer, Stephen Ross. J Psychopharmacol 2020
Gabrielle I Agin-Liebes, Tara Malone, Matthew M Yalch, Sarah E Mennenga, K Linnae Ponté, Jeffrey Guss, Anthony P Bossis, Jim Grigsby, Stacy Fischer, Stephen Ross. J Psychopharmacol 2020
28
Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness.
Katherine A MacLean, Matthew W Johnson, Roland R Griffiths. J Psychopharmacol 2011
Katherine A MacLean, Matthew W Johnson, Roland R Griffiths. J Psychopharmacol 2011
24
Long-term follow-up of psilocybin-facilitated smoking cessation.
Matthew W Johnson, Albert Garcia-Romeu, Roland R Griffiths. Am J Drug Alcohol Abuse 2017
Matthew W Johnson, Albert Garcia-Romeu, Roland R Griffiths. Am J Drug Alcohol Abuse 2017
23
Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.
Francisco A Moreno, Christopher B Wiegand, E Keolani Taitano, Pedro L Delgado. J Clin Psychiatry 2006
Francisco A Moreno, Christopher B Wiegand, E Keolani Taitano, Pedro L Delgado. J Clin Psychiatry 2006
23
Psilocybin-occasioned mystical experiences in the treatment of tobacco addiction.
Albert Garcia-Romeu, Roland R Griffiths, Matthew W Johnson. Curr Drug Abuse Rev 2014
Albert Garcia-Romeu, Roland R Griffiths, Matthew W Johnson. Curr Drug Abuse Rev 2014
23
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action.
F X Vollenweider, M F Vollenweider-Scherpenhuyzen, A Bäbler, H Vogel, D Hell. Neuroreport 1998
F X Vollenweider, M F Vollenweider-Scherpenhuyzen, A Bäbler, H Vogel, D Hell. Neuroreport 1998
22
Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later.
Rr Griffiths, Wa Richards, Mw Johnson, Ud McCann, R Jesse. J Psychopharmacol 2008
Rr Griffiths, Wa Richards, Mw Johnson, Ud McCann, R Jesse. J Psychopharmacol 2008
21
The Subjective Effects of Psychedelics Are Necessary for Their Enduring Therapeutic Effects.
David B Yaden, Roland R Griffiths. ACS Pharmacol Transl Sci 2020
David B Yaden, Roland R Griffiths. ACS Pharmacol Transl Sci 2020
25
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin.
Robin L Carhart-Harris, David Erritzoe, Tim Williams, James M Stone, Laurence J Reed, Alessandro Colasanti, Robin J Tyacke, Robert Leech, Andrea L Malizia, Kevin Murphy,[...]. Proc Natl Acad Sci U S A 2012
Robin L Carhart-Harris, David Erritzoe, Tim Williams, James M Stone, Laurence J Reed, Alessandro Colasanti, Robin J Tyacke, Robert Leech, Andrea L Malizia, Kevin Murphy,[...]. Proc Natl Acad Sci U S A 2012
20
LSD-assisted psychotherapy for anxiety associated with a life-threatening disease: a qualitative study of acute and sustained subjective effects.
Peter Gasser, Katharina Kirchner, Torsten Passie. J Psychopharmacol 2015
Peter Gasser, Katharina Kirchner, Torsten Passie. J Psychopharmacol 2015
20
Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects.
Friederike Holze, Patrick Vizeli, Laura Ley, Felix Müller, Patrick Dolder, Melanie Stocker, Urs Duthaler, Nimmy Varghese, Anne Eckert, Stefan Borgwardt,[...]. Neuropsychopharmacology 2021
Friederike Holze, Patrick Vizeli, Laura Ley, Felix Müller, Patrick Dolder, Melanie Stocker, Urs Duthaler, Nimmy Varghese, Anne Eckert, Stefan Borgwardt,[...]. Neuropsychopharmacology 2021
30
Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels.
Martin K Madsen, Patrick M Fisher, Daniel Burmester, Agnete Dyssegaard, Dea S Stenbæk, Sara Kristiansen, Sys S Johansen, Sczabolz Lehel, Kristian Linnet, Claus Svarer,[...]. Neuropsychopharmacology 2019
Martin K Madsen, Patrick M Fisher, Daniel Burmester, Agnete Dyssegaard, Dea S Stenbæk, Sara Kristiansen, Sys S Johansen, Sczabolz Lehel, Kristian Linnet, Claus Svarer,[...]. Neuropsychopharmacology 2019
20
Set and setting, psychedelics and the placebo response: An extra-pharmacological perspective on psychopharmacology.
Ido Hartogsohn. J Psychopharmacol 2016
Ido Hartogsohn. J Psychopharmacol 2016
19
Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin.
Frederick S Barrett, Matthew W Johnson, Roland R Griffiths. J Psychopharmacol 2015
Frederick S Barrett, Matthew W Johnson, Roland R Griffiths. J Psychopharmacol 2015
19
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.
Brian T Anderson, Alicia Danforth, Prof Robert Daroff, Christopher Stauffer, Eve Ekman, Gabrielle Agin-Liebes, Alexander Trope, Matthew Tyler Boden, Prof James Dilley, Jennifer Mitchell,[...]. EClinicalMedicine 2020
Brian T Anderson, Alicia Danforth, Prof Robert Daroff, Christopher Stauffer, Eve Ekman, Gabrielle Agin-Liebes, Alexander Trope, Matthew Tyler Boden, Prof James Dilley, Jennifer Mitchell,[...]. EClinicalMedicine 2020
26
The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.
Matthew W Johnson, Roland R Griffiths, Peter S Hendricks, Jack E Henningfield. Neuropharmacology 2018
Matthew W Johnson, Roland R Griffiths, Peter S Hendricks, Jack E Henningfield. Neuropharmacology 2018
18
Psychedelics and Psychedelic-Assisted Psychotherapy.
Collin M Reiff, Elon E Richman, Charles B Nemeroff, Linda L Carpenter, Alik S Widge, Carolyn I Rodriguez, Ned H Kalin, William M McDonald. Am J Psychiatry 2020
Collin M Reiff, Elon E Richman, Charles B Nemeroff, Linda L Carpenter, Alik S Widge, Carolyn I Rodriguez, Ned H Kalin, William M McDonald. Am J Psychiatry 2020
18
Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety.
Alan K Davis, Frederick S Barrett, Roland R Griffiths. J Contextual Behav Sci 2020
Alan K Davis, Frederick S Barrett, Roland R Griffiths. J Contextual Behav Sci 2020
23
Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.
Theresa M Carbonaro, Matthew P Bradstreet, Frederick S Barrett, Katherine A MacLean, Robert Jesse, Matthew W Johnson, Roland R Griffiths. J Psychopharmacol 2016
Theresa M Carbonaro, Matthew P Bradstreet, Frederick S Barrett, Katherine A MacLean, Robert Jesse, Matthew W Johnson, Roland R Griffiths. J Psychopharmacol 2016
17
Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors.
Roland R Griffiths, Matthew W Johnson, William A Richards, Brian D Richards, Robert Jesse, Katherine A MacLean, Frederick S Barrett, Mary P Cosimano, Maggie A Klinedinst. J Psychopharmacol 2018
Roland R Griffiths, Matthew W Johnson, William A Richards, Brian D Richards, Robert Jesse, Katherine A MacLean, Frederick S Barrett, Mary P Cosimano, Maggie A Klinedinst. J Psychopharmacol 2018
17
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study.
Rafael Faria Sanches, Flávia de Lima Osório, Rafael G Dos Santos, Ligia R H Macedo, João Paulo Maia-de-Oliveira, Lauro Wichert-Ana, Draulio Barros de Araujo, Jordi Riba, José Alexandre S Crippa, Jaime E C Hallak. J Clin Psychopharmacol 2016
Rafael Faria Sanches, Flávia de Lima Osório, Rafael G Dos Santos, Ligia R H Macedo, João Paulo Maia-de-Oliveira, Lauro Wichert-Ana, Draulio Barros de Araujo, Jordi Riba, José Alexandre S Crippa, Jaime E C Hallak. J Clin Psychopharmacol 2016
16
Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.
Erich Studerus, Michael Kometer, Felix Hasler, Franz X Vollenweider. J Psychopharmacol 2011
Erich Studerus, Michael Kometer, Felix Hasler, Franz X Vollenweider. J Psychopharmacol 2011
16
Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms.
Robin L Carhart-Harris, Leor Roseman, Mark Bolstridge, Lysia Demetriou, J Nienke Pannekoek, Matthew B Wall, Mark Tanner, Mendel Kaelen, John McGonigle, Kevin Murphy,[...]. Sci Rep 2017
Robin L Carhart-Harris, Leor Roseman, Mark Bolstridge, Lysia Demetriou, J Nienke Pannekoek, Matthew B Wall, Mark Tanner, Mendel Kaelen, John McGonigle, Kevin Murphy,[...]. Sci Rep 2017
16
Psychedelics and the essential importance of context.
Robin L Carhart-Harris, Leor Roseman, Eline Haijen, David Erritzoe, Rosalind Watts, Igor Branchi, Mendel Kaelen. J Psychopharmacol 2018
Robin L Carhart-Harris, Leor Roseman, Eline Haijen, David Erritzoe, Rosalind Watts, Igor Branchi, Mendel Kaelen. J Psychopharmacol 2018
15
Predicting Responses to Psychedelics: A Prospective Study.
Eline C H M Haijen, Mendel Kaelen, Leor Roseman, Christopher Timmermann, Hannes Kettner, Suzanne Russ, David Nutt, Richard E Daws, Adam D G Hampshire, Romy Lorenz,[...]. Front Pharmacol 2018
Eline C H M Haijen, Mendel Kaelen, Leor Roseman, Christopher Timmermann, Hannes Kettner, Suzanne Russ, David Nutt, Richard E Daws, Adam D G Hampshire, Romy Lorenz,[...]. Front Pharmacol 2018
15
Prediction of psilocybin response in healthy volunteers.
Erich Studerus, Alex Gamma, Michael Kometer, Franz X Vollenweider. PLoS One 2012
Erich Studerus, Alex Gamma, Michael Kometer, Franz X Vollenweider. PLoS One 2012
15
Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects.
Yasmin Schmid, Florian Enzler, Peter Gasser, Eric Grouzmann, Katrin H Preller, Franz X Vollenweider, Rudolf Brenneisen, Felix Müller, Stefan Borgwardt, Matthias E Liechti. Biol Psychiatry 2015
Yasmin Schmid, Florian Enzler, Peter Gasser, Eric Grouzmann, Katrin H Preller, Franz X Vollenweider, Rudolf Brenneisen, Felix Müller, Stefan Borgwardt, Matthias E Liechti. Biol Psychiatry 2015
15
The pharmacology of psilocybin.
Torsten Passie, Juergen Seifert, Udo Schneider, Hinderk M Emrich. Addict Biol 2002
Torsten Passie, Juergen Seifert, Udo Schneider, Hinderk M Emrich. Addict Biol 2002
15
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report.
Flávia de L Osório, Rafael F Sanches, Ligia R Macedo, Rafael G dos Santos, João P Maia-de-Oliveira, Lauro Wichert-Ana, Draulio B de Araujo, Jordi Riba, José A Crippa, Jaime E Hallak. Braz J Psychiatry 2015
Flávia de L Osório, Rafael F Sanches, Ligia R Macedo, Rafael G dos Santos, João P Maia-de-Oliveira, Lauro Wichert-Ana, Draulio B de Araujo, Jordi Riba, José A Crippa, Jaime E Hallak. Braz J Psychiatry 2015
14
Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory.
Leor Roseman, Eline Haijen, Kelvin Idialu-Ikato, Mendel Kaelen, Rosalind Watts, Robin Carhart-Harris. J Psychopharmacol 2019
Leor Roseman, Eline Haijen, Kelvin Idialu-Ikato, Mendel Kaelen, Rosalind Watts, Robin Carhart-Harris. J Psychopharmacol 2019
18
REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics.
R L Carhart-Harris, K J Friston. Pharmacol Rev 2019
R L Carhart-Harris, K J Friston. Pharmacol Rev 2019
14
Psychiatry & the psychedelic drugs. Past, present & future.
James J H Rucker, Jonathan Iliff, David J Nutt. Neuropharmacology 2018
James J H Rucker, Jonathan Iliff, David J Nutt. Neuropharmacology 2018
14
The Fabric of Meaning and Subjective Effects in LSD-Induced States Depend on Serotonin 2A Receptor Activation.
Katrin H Preller, Marcus Herdener, Thomas Pokorny, Amanda Planzer, Rainer Kraehenmann, Philipp Stämpfli, Matthias E Liechti, Erich Seifritz, Franz X Vollenweider. Curr Biol 2017
Katrin H Preller, Marcus Herdener, Thomas Pokorny, Amanda Planzer, Rainer Kraehenmann, Philipp Stämpfli, Matthias E Liechti, Erich Seifritz, Franz X Vollenweider. Curr Biol 2017
14
Psychedelic drugs: neurobiology and potential for treatment of psychiatric disorders.
Franz X Vollenweider, Katrin H Preller. Nat Rev Neurosci 2020
Franz X Vollenweider, Katrin H Preller. Nat Rev Neurosci 2020
14
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.